High expression of miR-25 predicts favorable chemotherapy outcome in patients with acute myeloid leukemia

BACKGROUND: Acute myeloid leukemia (AML) pertains to a hematologic malignancy with heterogeneous therapeutic responses. Improvements in risk stratification in AML patients are warranted. MicroRNAs have been associated with the pathogenesis of AML. METHODS: To examine the prognostic value of miR-25,...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Cell Int
Auteurs principaux: Niu, Mingshan, Feng, Yuan, Zhang, Ninghan, Shao, Tingting, Zhang, Huihui, Wang, Rong, Yao, Yao, Yao, Ruosi, Wu, Qingyun, Cao, Jiang, Liu, Xuejiao, Liu, Yubo, Xu, Kailin
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2019
Sujets:
Primary Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6505210/
https://ncbi.nlm.nih.gov/pubmed/31080363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-019-0843-9
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires